SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-18-007407
Filing Date
2018-01-09
Accepted
2018-01-09 17:19:25
Documents
11

Document Format Files

Seq Description Document Type Size
1 FORM S-3 d517642ds3.htm S-3 175713
2 EX-5.1 d517642dex51.htm EX-5.1 9963
3 EX-23.1 d517642dex231.htm EX-23.1 1978
4 EX-23.3 d517642dex233.htm EX-23.3 1647
5 EX-23.4 d517642dex234.htm EX-23.4 1639
6 GRAPHIC g517642g0109123013967.jpg GRAPHIC 3953
7 GRAPHIC g517642g02v59.jpg GRAPHIC 91394
8 GRAPHIC g517642g71z32.jpg GRAPHIC 75518
9 GRAPHIC g517642g88l11.jpg GRAPHIC 52905
10 GRAPHIC g517642g93c19.jpg GRAPHIC 88706
11 GRAPHIC g517642g95m85.jpg GRAPHIC 103616
  Complete submission text file 0001193125-18-007407.txt   765460
Mailing Address 300 GEORGE STREET SUITE 301 NEW HAVEN CT 06511
Business Address 300 GEORGE STREET SUITE 301 NEW HAVEN CT 06511 312 767 0291
MELINTA THERAPEUTICS, INC. /NEW/ (Filer) CIK: 0001461993 (see all company filings)

IRS No.: 454440364 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-222484 | Film No.: 18519777
SIC: 2834 Pharmaceutical Preparations